Kemble George (CIK 1858176) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Buy SGMT (326,618 shares), Buy SGMT (24,369 shares), Sell SGMT (350,987 shares), Buy SGMT (9,751 shares), Buy SGMT (10,455 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Sagimet Biosciences Inc. (SGMT) | Director | Buy | 326,618 | $2.1M |
| 2026-08-17 | Sagimet Biosciences Inc. (SGMT) | Director | Buy | 24,369 | $154,987 |
| 2026-08-17 | Sagimet Biosciences Inc. (SGMT) | Director | Sell | 350,987 | $3.6M |
| 2026-08-12 | Sagimet Biosciences Inc. (SGMT) | Director | Buy | 9,751 | $62,016 |
| 2026-08-12 | Sagimet Biosciences Inc. (SGMT) | Director | Buy | 10,455 | $66,494 |
| 2026-08-12 | Sagimet Biosciences Inc. (SGMT) | Director | Sell | 20,206 | $201,147 |
| 2026-07-22 | Sagimet Biosciences Inc. (SGMT) | Director | Sell | 18,844 | $140,529 |
| 2025-11-21 | Sagimet Biosciences Inc. (SGMT) | Executive Chairman | Sell | 37,688 | $289,821 |
Source: SEC Form 4 filings · as of 2026-08-17